Nurix Therapeutics Inc (NRIX)

R&D Expense Growth

-9.58%

Quarterly · Period ending:

NRIX logo

NRIX R&D Expense Growth

Latest reported-9.58%
NRIX Quarterly R&D Growth (QoQ) (0.00% → -9.58%)
High-resolution chart · PNG

NRIX r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Nurix Therapeutics Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
-9.5753%
4.1789%
3.9961%
-6.0567%
10.2745%
12.1054%
3.6282%
21.1658%
13.4071%
-2.1658%
0.5874%
3.8804%
4.5736%
-0.1157%
-0.629%
-3.4652%
0.5643%
10.0981%
18.0833%
18.2003%
18.8967%
13.0027%
12.5116%
7.9518%
33.9202%
9.0615%
1.1151%
16.4971%
2.3143%
3.1148%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.